Know Labs (KNW) Stock Price, News & Analysis

Company Overview

Know Labs, Inc. (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways. Know Labs has assembled a patent portfolio covering hardware design, signal analysis and data‐interpretation methods, and is collaborating with academic and industry partners to refine its technology. These collaborations are intended to demonstrate the accuracy, reliability and safety of non‐invasive measurements across applications in diabetes management, sports performance, consumer wellness and beyond.

Headquartered in the United States, Know Labs is positioning its Bio‐RFID platform for global deployment, with initial emphasis on markets that demand painless, continuous biomarker tracking. The management team brings together expertise in biomedical engineering, product development and medical‐device commercialization. As the company advances toward regulatory clearance and potential strategic partnerships, it aims to license its technology to device manufacturers or offer integrated solutions directly to end users.

Key Stats

• Today's Range: $2.00 to $2.17
• 50-Day Range: $2.06 to $2.86
• 52-Week Range: $0.33 to $14.80
• Volume: 612,050 shs
• Average Volume: 381,756 shs
• Market Capitalization: $16.04 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KNW Stock Analysis - Frequently Asked Questions

How have KNW shares performed this year?

Know Labs' stock was trading at $6.8840 at the beginning of the year. Since then, KNW shares have decreased by 68.9% and is now trading at $2.1390.

How were Know Labs' earnings last quarter?

Know Labs, Inc. (NYSEAMERICAN:KNW) released its earnings results on Friday, February, 14th. The company reported ($1.60) earnings per share for the quarter.
Read the conference call transcript.

When did Know Labs' stock split?

Know Labs shares reverse split on Tuesday, February 18th 2025.The 1-40 reverse split was announced on Tuesday, February 18th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, February 19th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of Know Labs?

Shares of KNW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Know Labs own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Know Labs investors own include Broadcom (AVGO), Arista Networks (ANET), NVIDIA (NVDA), Adobe (ADBE), Disc Medicine (IRON), Jabil (JBL) and AppLovin (APP).

Company Calendar

• Last Earnings: 2/14/2025
• Today: 10/01/2025
• Fiscal Year End: 9/30/2026

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Business Services
• Industry: Technology Services
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: NYSEAMERICAN:KNW
• Previous Symbol: OTCMKTS:KNWN
• CIK: 1074828
• Web: www.knowlabs.co
• Phone: (206) 903-1351
• Fax: 206-826-0451
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.20)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$16.58 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -809.17%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.03
• Quick Ratio: 0.03

Sales & Book Value

• Annual Sales: $4.36 million
• Price / Sales: 3.68
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.80) per share
• Price / Book: -2.67

Miscellaneous

• Outstanding Shares: 7,500,000
• Free Float: 4,815,000
• Market Cap: $16.04 million
• Optionable: Not Optionable
• Beta: 1.83